$15.62
+0.31
(+2.02%)▲
Live
Revenue is up for the last 2 quarters, 2.52B → 2.56B (in $), with an average increase of 1.6% per quarter
Netprofit is down for the last 2 quarters, -24.41M → -28.24M (in $), with an average decrease of 15.7% per quarter
In the last 1 year, Cardinal Health, Inc. has given 24.4% return, outperforming this stock by 63.7%
In the last 3 years, Mckesson Corporation has given 87.5% return, outperforming this stock by 119.5%
1.73%
Downside
Day's Volatility :2.48%
Upside
0.76%
24.52%
Downside
52 Weeks Volatility :53.73%
Upside
38.7%
Period | Owens & Minor Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -14.13% | -3.2% | 0.0% |
6 Months | 4.01% | -2.7% | 0.0% |
1 Year | -39.32% | 0.8% | -0.4% |
3 Years | -37.15% | 22.3% | 14.9% |
Market Capitalization | 1.3B |
Book Value | $11.73 |
Dividend Share | 0.0 |
Dividend Yield | 0.05% |
Earnings Per Share (EPS) | -1.31 |
PEG Ratio | 4.07 |
Wall Street Target Price | 20.4 |
Profit Margin | -0.97% |
Operating Margin TTM | 0.81% |
Return On Assets TTM | 0.94% |
Return On Equity TTM | -10.58% |
Revenue TTM | 10.1B |
Revenue Per Share TTM | 134.78 |
Quarterly Revenue Growth YOY | 2.5% |
Gross Profit TTM | 1.8B |
EBITDA | 342.0M |
Diluted Eps TTM | -1.31 |
Quarterly Earnings Growth YOY | -0.72 |
EPS Estimate Current Year | 1.42 |
EPS Estimate Next Year | 2.13 |
EPS Estimate Current Quarter | 0.17 |
EPS Estimate Next Quarter | 0.48 |
What analysts predicted
Upside of 30.6%
FY17 | Y/Y Change | |
---|---|---|
Revenue | 9.3B | ↓ 4.17% |
Net Income | 72.8M | ↓ 33.09% |
Net Profit Margin | 0.78% | ↓ 0.34% |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 9.8B | ↑ 5.59% |
Net Income | -437.0M | ↓ 700.35% |
Net Profit Margin | -4.44% | ↓ 5.22% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 9.2B | ↓ 6.38% |
Net Income | -62.4M | ↓ 85.73% |
Net Profit Margin | -0.68% | ↑ 3.76% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 8.5B | ↓ 7.93% |
Net Income | 29.9M | ↓ 147.89% |
Net Profit Margin | 0.35% | ↑ 1.03% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 9.8B | ↑ 15.39% |
Net Income | 221.6M | ↑ 641.82% |
Net Profit Margin | 2.26% | ↑ 1.91% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 10.0B | ↑ 1.74% |
Net Income | 22.4M | ↓ 89.9% |
Net Profit Margin | 0.22% | ↓ 2.04% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.4B | ↓ 2.44% |
Net Income | 39.3M | ↓ 6.42% |
Net Profit Margin | 1.63% | ↓ 0.07% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.5B | ↑ 3.87% |
Net Income | 28.6M | ↓ 27.18% |
Net Profit Margin | 1.14% | ↓ 0.49% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.5B | ↓ 0.1% |
Net Income | 12.5M | ↓ 56.31% |
Net Profit Margin | 0.5% | ↓ 0.64% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.6B | ↑ 2.15% |
Net Income | -58.0M | ↓ 564.05% |
Net Profit Margin | -2.27% | ↓ 2.77% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.5B | ↓ 1.11% |
Net Income | -24.4M | ↓ 57.89% |
Net Profit Margin | -0.97% | ↑ 1.3% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.6B | ↑ 1.6% |
Net Income | -28.2M | ↑ 15.66% |
Net Profit Margin | -1.1% | ↓ 0.13% |
FY17 | Y/Y Change | |
---|---|---|
Total Assets | 3.4B | ↑ 24.23% |
Total Liabilities | 2.4B | ↑ 34.31% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 3.8B | ↑ 11.77% |
Total Liabilities | 3.3B | ↑ 37.89% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 3.6B | ↓ 3.46% |
Total Liabilities | 3.2B | ↓ 2.29% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 3.3B | ↓ 8.44% |
Total Liabilities | 2.6B | ↓ 17.52% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 3.5B | ↑ 6.02% |
Total Liabilities | 2.6B | ↓ 0.97% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 5.4B | ↑ 52.3% |
Total Liabilities | 4.4B | ↑ 70.92% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.7B | ↑ 61.4% |
Total Liabilities | 4.8B | ↑ 83.23% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.6B | ↓ 2.68% |
Total Liabilities | 4.6B | ↓ 3.44% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.5B | ↓ 0.3% |
Total Liabilities | 4.6B | ↓ 0.54% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.4B | ↓ 2.75% |
Total Liabilities | 4.4B | ↓ 2.87% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.3B | ↓ 1.41% |
Total Liabilities | 4.4B | ↓ 1.24% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.3B | ↓ 0.42% |
Total Liabilities | 4.4B | ↑ 0.14% |
FY17 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 56.8M | ↓ 69.63% |
Investing Cash Flow | -416.6M | ↑ 1583.68% |
Financing Cash Flow | 272.8M | ↓ 292.19% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 115.6M | ↑ 103.59% |
Investing Cash Flow | -815.8M | ↑ 95.81% |
Financing Cash Flow | 701.1M | ↑ 156.99% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 166.1M | ↑ 43.69% |
Investing Cash Flow | -51.9M | ↓ 93.64% |
Financing Cash Flow | -130.2M | ↓ 118.57% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 339.2M | ↑ 104.25% |
Investing Cash Flow | 80.1M | ↓ 254.29% |
Financing Cash Flow | -379.4M | ↑ 191.39% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 124.2M | ↓ 63.39% |
Investing Cash Flow | -53.6M | ↓ 166.98% |
Financing Cash Flow | -129.5M | ↓ 65.87% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 325.0M | ↑ 161.73% |
Investing Cash Flow | -1.8B | ↑ 3264.68% |
Financing Cash Flow | 1.5B | ↓ 1256.26% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 79.7M | ↑ 58.32% |
Investing Cash Flow | -1.6B | ↑ 7441.75% |
Financing Cash Flow | 1.7B | ↓ 13678.61% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 89.8M | ↑ 12.71% |
Investing Cash Flow | -158.1M | ↓ 90.04% |
Financing Cash Flow | -83.6M | ↓ 105.02% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 68.5M | ↓ 23.72% |
Investing Cash Flow | -26.4M | ↓ 83.29% |
Financing Cash Flow | -20.0M | ↓ 76.01% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 87.0M | ↑ 26.91% |
Investing Cash Flow | -1.8B | ↑ 6733.58% |
Financing Cash Flow | -63.5M | ↑ 216.64% |
Sell
Neutral
Buy
Owens & Minor Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Owens & Minor Inc | -13.06% | 4.01% | -39.32% | -37.15% | -5.96% |
![]() Cardinal Health, Inc. | -0.09% | 13.27% | 24.36% | 84.16% | 62.03% |
![]() Cencora Inc | 4.28% | 0.77% | 0.77% | 44.83% | 70.63% |
![]() Mckesson Corporation | 7.7% | 20.8% | 23.39% | 193.93% | 231.54% |
![]() Henry Schein, Inc. | -2.37% | -11.47% | 4.12% | 20.69% | 6.71% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Owens & Minor Inc | 24.91 | NA | 4.07 | 1.42 | -0.11 | 0.01 | 0.0 | 11.73 |
![]() Cardinal Health, Inc. | 86.38 | 86.38 | 0.65 | 5.74 | 0.0 | 0.03 | 0.02 | -11.36 |
![]() Cencora Inc | 21.28 | 21.28 | 1.58 | 11.93 | 2.34 | 0.03 | 0.01 | 3.39 |
![]() Mckesson Corporation | 16.3 | 16.3 | 0.62 | 25.95 | 0.0 | 0.04 | 0.01 | -11.87 |
![]() Henry Schein, Inc. | 21.43 | 21.43 | 1.94 | 5.27 | 0.1 | 0.06 | 0.0 | 27.26 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Owens & Minor Inc | Sell | $1.3B | -5.96% | 24.91 | -0.97% |
![]() Cardinal Health, Inc. | Hold | $21.3B | 62.03% | 86.38 | 0.13% |
![]() Cencora Inc | NA | $35.1B | 70.63% | 21.28 | 0.66% |
![]() Mckesson Corporation | Buy | $59.0B | 231.54% | 16.3 | 1.32% |
![]() Henry Schein, Inc. | Hold | $9.6B | 6.71% | 21.43 | 3.64% |
BlackRock Inc
FMR Inc
Vanguard Group Inc
Wellington Management Company LLP
Deerfield Management Co
Dimensional Fund Advisors, Inc.
In the quarter ending June,2021. Owens & Minor Inc has declared dividend of $0.0
Read Moreowens & minor, inc. (nyse: omi) is a leading healthcare logistics company dedicated to connecting the world of medical products to the point of care by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. owens & minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. with logistics platforms strategically located in the united states and europe, owens & minor serves markets where three quarters of global healthcare spending occurs. owens & minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, and the federal government. a fortune 500 company, owens & minor is headquartered in richmond, virginia, and has annualized revenues exceeding $9 billion. for more information about owens & minor, visit the company website at www.owens-m
Organization | Owens & Minor Inc |
Employees | 22500 |
CEO | Mr. Edward A. Pesicka |
Industry | Medical Distributors |